Advanced search

Find pages with...
Then narrow your results by...

About 1 search results

AVANDIA, AVANDAMET and AVANDARYL - Important New Restrictions on the Use of Rosiglitazone Products Due to Information on Cardiovascular Related Events - For Health Professionals

Mar 5, 2013 ... control or are inappropriate due to contraindications or intolerance. Prior to starting or renewing a prescription for AVANDIA®/AVANDAMET®/AVANDARYL®, physicians should consider whether a rosiglitazone-containing product is an appropriate therapeutic choice, and if so: Document the eligibility of patients to meet the above criteria; Counsel each patient

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: